Related Experiment Video
Updated: Sep 28, 2025

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
Published on: May 8, 2017
Factors in childhood associated with lung function decline to adolescence in cystic fibrosis
Nelufa Begum1, Catherine A Byrnes2, Joyce Cheney3
1Children's Health and Environment Program, Child Health Research Centre, The University of Queensland, 62 Graham St, South Brisbane, QLD 4101, Australia.
Insights
Early childhood hospitalizations and neutrophil elastase activity in children with cystic fibrosis (CF) predict lung function decline. Interventions targeting these factors in early life may improve long-term respiratory health in CF patients.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
- Genetics and Disease
Background:
- Cystic Fibrosis (CF) is a genetic disorder affecting multiple organs, primarily the lungs.
- Despite advances in care, progressive lung function decline remains a significant challenge for individuals with CF, particularly during adolescence and early adulthood.
- Understanding early-life predictors of lung function decline is crucial for developing targeted interventions.
Purpose of the Study:
- To identify factors present at age 5 years that predict lung function decline from childhood to adolescence in children with CF.
- To analyze lung function trajectories in a longitudinal cohort of Australasian children with CF.
Main Methods:
- A longitudinal study followed 119 Australasian children with CF from 1999 to 2017.
- Lung function was assessed from childhood (median age 5.0 years) to early adolescence (median age 12.5 years).
- Multivariable analyses examined predictors of lung function decline, including hospitalization history and bronchoalveolar lavage neutrophil elastase activity.
Main Results:
- Lung function progressively declined in children with CF, with significant annual decreases in forced vital capacity (FVC) Z-score, forced expiratory volume in 1-second (FEV1) Z-score, FEV1/FVC ratio, and forced expiratory flow between 25% and 75% of FVC (FEF25-75) Z-score.
- Childhood hospitalization for respiratory exacerbations and higher bronchoalveolar lavage neutrophil elastase activity at age 5 predicted greater lung function decline in adolescence.
- No factors examined predicted a decline in FVC Z-score.
Conclusions:
- Preventing and treating respiratory exacerbations and managing neutrophilic inflammation in the early years of life are potential strategies to mitigate lung function decline in children with CF.
- These early-life factors represent critical targets for future research and therapeutic interventions in pediatric CF care.
Background:
Despite improvements in general health and life expectancy in people with cystic fibrosis (CF), lung function decline continues unabated during adolescence and early adult life.
Methods:
We examined factors present at age 5-years that predicted lung function decline from childhood to adolescence in a longitudinal study of Australasian children with CF followed from 1999 to 2017.
Results:
Lung function trajectories were calculated for 119 children with CF from childhood (median 5.0 [25%-75%=5.0-5.1]) years) to early adolescence (median 12.5 [25%-75%=11.4-13.8] years). Lung function fell progressively, with mean (standard deviation) annual change -0.105 (0.049) for forced vital capacity (FVC) Z-score (p<0.001), -0.135 (0.048) for forced expiratory volume in 1-second (FEV1) Z-score (p<0.001), -1.277 (0.221) for FEV1/FVC% (p<0.001), and -0.136 (0.052) for forced expiratory flow between 25% and 75% of FVC Z-score (p<0.001). Factors present in childhood predicting lung function decline to adolescence, in multivariable analyses, were hospitalisation for respiratory exacerbations in the first 5-years of life (FEV1/FVC p = 0.001, FEF25-75p = 0.01) and bronchoalveolar lavage neutrophil elastase activity (FEV1/FVC% p = 0.001, FEV1p = 0.05, FEF25-75p = 0.02). No examined factor predicted a decline in the FVC Z-score.
Conclusions:
Action in the first 5-years of life to prevent and/or treat respiratory exacerbations and counteract neutrophilic inflammation in the lower airways may reduce lung function decline in children with CF, and these should be targets of future research.
More Related Videos
07:38Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome
Published on: August 3, 2021
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Factors Affecting Pulmonary Ventilation
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...